Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of Pulmonary Arterial Hypertension at the American Thoracic Society 2017 International Conference

SAN DIEGO May 16 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA will present detailed Phase 1 data on ralinepag APD811 the Company's nextgeneration oral selective prostacyclin receptor IP agonist intended for the treatment of pulmonary arterial hy...